Dark-spot creams: compare the category before the claim

Spot On is described as a compounded cream with hydroquinone, kojic acid and niacinamide. Its plan cards state 6% for each of the first two ingredients, leaving niacinamide’s percentage, the complete base and supplied amount unresolved. The CoreAge review distinguishes these public specifications from an inspected prescription. Product description Current offer

The main offers show $165 for three months and $70 for one month, accompanied by $54.99 and $69.99 monthly displays. A separate Spot On description says $42 monthly without a matching checked plan. Those figures cannot be silently reconciled into a more attractive price.

Obagi presents Clear Fx as a skin-brightening cream with arbutin and antioxidants. Its disclosed ingredient list does not name hydroquinone, and its regular-price display is $125. Direct page text separately offers a 15% subscription promotion with selectable delivery frequencies. The price and subscription controls identify a commercial offer, not an assessed treatment duration or a verified stock position. Clear Fx page

The Clear Fx article treats this as the retail appearance-focused record Obagi presents. It does not certify a legal product classification merely because the page uses cosmetic language. FDA explains that intended use, including online claims, affects whether a product is a cosmetic, drug or both. FDA category explanation

Obagi Nu-Derm Clear’s prescription page identifies a cream containing hydroquinone 4% and directs readers to a healthcare provider. That is different from the arbutin-based Fx page, even though their names and stated appearance concerns resemble one another. The $125 Fx display is not a verified Clear Rx quote. Prescription Clear record

Nor does the prescription requirement prove FDA approval. FDA’s hydroquinone communication names Tri-Luma in its approval statement; approval cannot be transferred through a shared active ingredient. A comparison that merges Rx and Fx would therefore confuse both product identity and the evidence being cited. FDA hydroquinone record

Dermatica’s melasma page publishes a menu that includes hydroquinone 4%, other prescription actives and a SmartBase cream description. Its homepage describes compounded personalized treatment. Neither page proves which ingredients a particular person would receive. A separately displayed retinal serum is not the custom hydroquinone preparation. Treatment page Homepage

Current pricing is $29.95 per bottle and $59.90 every two months, with free shipping and approximately 56-day delivery language. The Dermatica review reads those units alongside its check-in claims rather than making an annual total or a universal formula assumption. Pricing record

The Clear Fx page includes an automated summary of customer reviews. CoreAge describes patient experiences with an explicit personal-outcome disclaimer. Dermatica’s pricing page presents stories concerning several different skin goals. Each is a record of what the website publishes, not a controlled comparison of the products discussed here. Fx reviews CoreAge disclosure Dermatica stories

FTC guidance distinguishes testimonials from scientific substantiation of health-product effects. We have not authenticated or debunked any individual story. The testimonial guide asks what evidence is missing rather than converting the number or enthusiasm of reviews into a clinical score. FTC guidance

AAD describes the assessment needed to distinguish melasma from another skin condition and explains that care is individualized. A reader’s concern about a mark does not automatically match a condition named on a commercial page. Ingredient comparisons cannot repair that uncertainty. AAD diagnosis and treatment

Similarly, FDA’s explanation of compounded medicines does not make a compound equivalent to an approved preparation. The active-name guide keeps the preparation and evidence together. No larger percentage, longer ingredient list or stronger marketing adjective earns a preferred position on clinical grounds in this publication. FDA compounding

For a retail offer, unresolved questions may include the selected purchase option, shipment contents and applicable return conditions. A prescription route additionally requires the proposed preparation and the responsible professional’s explanation. None of these websites was tested through purchase or care, so their public promises should not be reported as completed service outcomes.

Our price-record guide helps preserve contradictory amounts, while the label-question guide separates a website from a supplied product. The comparison leaves room for a professional assessment or an unresolved question. It does not turn either a cosmetic interest or a concern about pigmentation into an obligation to buy.